Endolift sits in the gap between a laser facial and a surgical lift: more than a topical device can do, far less than a facelift, and delivered through a fiber thinner than a hair. If the jawline and the area under the chin are what bother you, here is how it works, what the FDA record actually says, and how it compares with the alternatives.
What Endolift is
Endolift is a technique performed with a 1470 nm diode laser delivered through a bare optical microfiber. The fiber — typically 200 or 300 microns for facial work, thinner than a strand of hair — is passed under the skin into the superficial fat layer without an incision. Laser energy is delivered along controlled paths, heating tissue to roughly 65 to 70 °C while the skin surface stays below 40 °C.
Two things happen at that temperature. The fibrous septae — the connective strands that tether skin to the deeper layers and slacken with age — contract. And the controlled thermal stimulus triggers new collagen formation in the treated plane. The manufacturer describes the fibers as creating micro-tunnels aligned with the antigravity vectors of the face, remodelling the septae without ablating tissue.
Treatment takes roughly 45 to 60 minutes for the lower face. It is done under local anesthesia, through entry points rather than incisions, and there are no sutures.
The FDA record, stated precisely
Most pages on this subject say “FDA-cleared” or, worse, “FDA-approved” and leave it there. The accurate version is more useful.
Endolift is performed with the Eufoton LASEmaR 1500, a Class II powered laser surgical instrument. It holds FDA 510(k) clearance — most recently K260489, cleared 29 May 2026, with the original clearance K092860 dating to 2010. The cleared indications cover surgical applications requiring vaporization, incision, excision, ablation, cutting and coagulation across specialties including plastic and aesthetic medicine, and laser-assisted lipolysis.
What those clearances do not contain: the words “skin tightening,” “lifting,” “facelift,” “jawline” or “submental.” Nor is “Endolift” itself an FDA clearance category — it is the name of a technique, and procedures are never FDA-approved.
So the honest framing is this: the laser is FDA-cleared; using it for facial skin tightening and jawline definition is an off-label application of a cleared device, chosen by a licensed provider. That is a normal and legal practice-of-medicine decision, and it is also worth knowing before you spend several thousand dollars. It is worth adding that 510(k) clearance is a finding of substantial equivalence to an existing device — it is not an FDA determination that a device is effective for a given cosmetic result.
What the research shows
The published evidence is early-stage, and it points both ways.
A 2024 systematic review in Aesthetic Plastic Surgery examined 23 studies and reported a favourable efficacy and safety profile for dermatological aesthetic use, with adverse events described as mild and self-limiting across all studies — while noting the evidence sits at levels III and IV and calling for controlled trials with larger samples.
The strongest single study for the lower face is a randomized controlled trial published in Laser Therapy in 2022, covering 96 subjects aged 45 to 55 with grade 4 ptosis of the lower third of the face, assessed at 60, 120 and 540 days. There is also a published case report using a 400-micron fiber that documented visible submental fat reduction after a single session, with photographs at 60 and 180 days — though a case report is one patient, and we present it as such.
The counterweight matters too. A 2025 review in Lasers in Medical Science screened 111 articles, included seven, and concluded that those articles showed a high risk of bias and a lack of standardization in treatment parameters, making the efficacy and safety of Endolift “challenging” to assert. We would rather show you that review than hide it.
How it compares
This is the comparison most clinics blur, so here it is straight:
- Ultherapy uses focused ultrasound and holds an explicit FDA clearance to lift lax submental and neck tissue. It is non-invasive — nothing goes under the skin — and it is generally the more conservative option.
- Kybella is deoxycholic acid, an FDA-approved drug indicated specifically for improving the appearance of moderate to severe submental fat. It dissolves fat but does not tighten skin, and usually requires multiple sessions with significant swelling.
- Morpheus8 is fractional radiofrequency microneedling, cleared for coagulation and, since 2024, contraction of soft tissue. It works from the surface downward rather than from within the fat layer.
- A surgical facelift or neck lift removes and repositions tissue. Results last many years. Endolift results are generally described as lasting one to two years — the longest published follow-up runs to about 18 months. Any claim of five permanent years is marketing, not data.
Endolift’s distinguishing feature is that it addresses both the fat layer and skin laxity from within, through a fiber, in a single session. Its distinguishing weakness is that its evidence base is thinner than Ultherapy’s or Kybella’s, and its cleared indication does not name what most people are buying it for.
Recovery, side effects and risks
Expect swelling and bruising. Most people are presentable within a few days, though some clinics describe up to one to two weeks before returning to social activities depending on the area and the individual. Numbness in the treated area is common and temporary. Firmness or small nodules under the skin can appear as tissue settles.
The published complication literature also reports rarer events: burns, peripheral neuropathy, local infection, hematoma, hyperpigmentation and fat necrosis. These are uncommon but they are documented, and they are technique-dependent — which is the argument for choosing an experienced provider rather than the lowest price.
Endolift is not appropriate during pregnancy, with active infection in the treatment area, for people with significant skin laxity that genuinely requires surgery, or where a bleeding disorder or certain medications make the procedure unsafe. We will tell you honestly at consultation if surgery would serve you better.
Results timeline
Some tightening is visible within the first weeks as swelling resolves, but the meaningful change is collagen-driven and builds over three to six months. Most people are treated once per area. This is not a treatment you evaluate at two weeks.
What it costs
- Endolift Face & Double Chin — starting at $2,500
- Endolift Abdominal Area — starting at $4,200, 55 minutes
For reference, US clinics commonly charge $2,300 to $3,500 for a single facial area and $5,000 to $8,000 for full face and neck; RealSelf reports a national average of $4,133. Endolift is cosmetic and not covered by insurance. Financing with 0% APR options and no hard credit check is available.
Frequently asked questions
Does it hurt? Local anesthesia is used. Most people describe pressure and warmth during, and soreness for a few days after.
How many sessions will I need? Usually one per area. We reassess at three months.
How long do results last? Generally one to two years. Aging continues underneath.
Is it a substitute for a facelift? No. It is an option some people consider instead of surgery, with a smaller result and a shorter recovery.
Can I combine it with other treatments? Yes — commonly with injectables, scheduled once the treated area has settled.
Who performs it? A licensed provider under medical direction. Ask this everywhere, not just here.
The right answer for your jawline depends on how much of the problem is fat, how much is laxity, and how much is bone structure. That is a consultation, not a web page. Book at West Palm Beach or Fort Myers, or see all treatments and prices.
This article is general information, not medical advice. Results vary between individuals. The laser used for Endolift is FDA-cleared as a surgical laser including for laser-assisted lipolysis; use for facial skin tightening is an off-label application of a cleared device. Treatment is provided following evaluation by a licensed provider.
Sources
- FDA 510(k) K260489 — Eufoton LASEmaR 1500, cleared 29 May 2026
- FDA 510(k) K092860 — original LASEmaR clearance
- Nilforoushzadeh et al., Aesthetic Plastic Surgery 2024 — systematic review of the intralesional 1470 nm diode laser
- Modena et al., Lasers in Medical Science 2025 — is there evidence for Endolift?
- Longo et al., Laser Therapy 2022 — randomized controlled trial, 96 subjects, lower third of the face
- dos Santos Borges et al. 2023 — complications from laser Endolift use
- FDA 510(k) K180623 — Ulthera System submental and neck lifting indication
- FDA — Kybella (deoxycholic acid) prescribing information